WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015115886) METHOD FOR TREATING, STABILIZING OR SLOWING DOWN BRAIN GLUCOSE METABOLISM DEFICIT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/115886    International Application No.:    PCT/NL2014/050059
Publication Date: 06.08.2015 International Filing Date: 31.01.2014
IPC:
A23L 1/30 (2006.01), A61K 45/06 (2006.01), A61K 31/14 (2006.01), A61K 31/202 (2006.01), A61K 31/355 (2006.01), A61K 31/375 (2006.01), A61K 31/4415 (2006.01), A61K 31/519 (2006.01), A61K 31/683 (2006.01), A61K 31/685 (2006.01), A61K 31/7068 (2006.01), A61K 31/7072 (2006.01), A61K 31/714 (2006.01), A61K 33/04 (2006.01), A61P 25/28 (2006.01)
Applicants: N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186 NL-2712 HM Zoetermeer (NL)
Inventors: BROERSEN, Ladislaus Maria; (NL).
HAGEMAN, Robert Johan Joseph; (NL).
LANSBERGEN, Marieke; (NL).
GROENENDIJK, Martine; (NL).
DE WILDE, Mattheus Cornelis; (NL)
Agent: NEDERLANDSCH OCTROOIBUREAU; Anna van Buerenplein 21 A 2595 DA The Hague (NL)
Priority Data:
Title (EN) METHOD FOR TREATING, STABILIZING OR SLOWING DOWN BRAIN GLUCOSE METABOLISM DEFICIT
(FR) PROCÉDÉ POUR TRAITER, STABILISER OU FREINER LES DÉFICITS DU MÉTABOLISME DU GLUCOSE DANS LE CERVEAU
Abstract: front page image
(EN)The invention pertains to the use of (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof, and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof in the manufacture of a composition for use in a method for treating, stabilizing or slowing down brain glucose metabolism deficit in a subject in need thereof.
(FR)L'invention concerne l'utilisation de (i) un ou plusieurs composés parmi l'uridine et la cytidine ou des sels, des phosphates, des dérivés d'acyle ou des esters de ceux-ci; et (ii) une fraction lipidique comprenant au moins un acide parmi l'acide docosahexaénoïque (22:6; DHA), l'acide eicosapentaénoïque (20:5; EPA) et l'acide docosapentaénoïque (22:5; DPA) ou leurs esters, dans le cadre de la préparation d'une composition s'utilisant dans une méthode pour traiter, stabiliser ou freiner les déficits du métabolisme du glucose dans le cerveau chez un sujet en ayant besoin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)